Lv1
40 积分 2025-01-20 加入
Shifting trends in bloodstream infection-causing microorganisms and their clinical impact in patients with haematologic malignancies in South Korea: A propensity score-matched study
3个月前
已完结
[Clinical practice guidelines for the diagnosis and management of invasive pulmonary fungal diseases (2025 Edition)]
4个月前
已完结
[The Chinese guidelines for the diagnosis and treatment of invasive fungal disease in patients with hematological disorders and cancers (the seventh revision)]
4个月前
已关闭
In vitro activity of imipenem-relebactam against KPC-producing Klebsiella pneumoniae resistant to ceftazidime-avibactam and/or meropenem-vaborbactam
8个月前
已完结
In vitro activity of imipenem/relebactam against Gram-negative clinical isolates in two Spanish tertiary hospitals
8个月前
已关闭
Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination
8个月前
已完结
Emerging resistance mechanisms to newer β-lactams in Pseudomonas aeruginosa
8个月前
已完结
Neutrophil Lifespan Extension with CLON-G and an <em>In Vitro</em> Spontaneous Death Assay
8个月前
已完结
New Delhi metallo-β-lactamase-producing Acinetobacter baumannii in the USA from October, 2013, to March, 2022: a retrospective molecular epidemiological analysis
8个月前
已完结
Therapeutic challenges in treating ESBL- and/or AmpC-producing non-carbapenemase-producing Enterobacterales : an in vitro evaluation of novel β-lactam/β-lactamase inhibitor combinations and cefiderocol
9个月前
已完结
皖公网安备34019202002308
